Cargando…
Rapid sequence induction with rocuronium - a challenge to the gold standard
Succinylcholine has been indicted on account of the diverse risks associated with its administration, which include hyperkalemia, vagal arrest, and malignant hyperthermia. However, it provides excellent intubating conditions reliably and quickly, characteristics that sustain its appeal for use in th...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334740/ https://www.ncbi.nlm.nih.gov/pubmed/22112346 http://dx.doi.org/10.1186/cc10418 |
_version_ | 1782230675896664064 |
---|---|
author | Curley, Gerard F |
author_facet | Curley, Gerard F |
author_sort | Curley, Gerard F |
collection | PubMed |
description | Succinylcholine has been indicted on account of the diverse risks associated with its administration, which include hyperkalemia, vagal arrest, and malignant hyperthermia. However, it provides excellent intubating conditions reliably and quickly, characteristics that sustain its appeal for use in the intensive care unit, where airway management is challenging. There is an increasing body of evidence, outlined here, that rocuronium is an acceptable alternative to succinylcholine. |
format | Online Article Text |
id | pubmed-3334740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33347402012-09-23 Rapid sequence induction with rocuronium - a challenge to the gold standard Curley, Gerard F Crit Care Commentary Succinylcholine has been indicted on account of the diverse risks associated with its administration, which include hyperkalemia, vagal arrest, and malignant hyperthermia. However, it provides excellent intubating conditions reliably and quickly, characteristics that sustain its appeal for use in the intensive care unit, where airway management is challenging. There is an increasing body of evidence, outlined here, that rocuronium is an acceptable alternative to succinylcholine. BioMed Central 2011 2011-09-23 /pmc/articles/PMC3334740/ /pubmed/22112346 http://dx.doi.org/10.1186/cc10418 Text en Copyright ©2011 BioMed Central Ltd |
spellingShingle | Commentary Curley, Gerard F Rapid sequence induction with rocuronium - a challenge to the gold standard |
title | Rapid sequence induction with rocuronium - a challenge to the gold standard |
title_full | Rapid sequence induction with rocuronium - a challenge to the gold standard |
title_fullStr | Rapid sequence induction with rocuronium - a challenge to the gold standard |
title_full_unstemmed | Rapid sequence induction with rocuronium - a challenge to the gold standard |
title_short | Rapid sequence induction with rocuronium - a challenge to the gold standard |
title_sort | rapid sequence induction with rocuronium - a challenge to the gold standard |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334740/ https://www.ncbi.nlm.nih.gov/pubmed/22112346 http://dx.doi.org/10.1186/cc10418 |
work_keys_str_mv | AT curleygerardf rapidsequenceinductionwithrocuroniumachallengetothegoldstandard |